tsRNADisease v1.0
The tsRNA and Disease Database (version 1.0)
Home
Search
Browse
Blast
Statistics
Download
Submit
Help
Entry Detail
General Information
Database ID:
TRD01183
Confidence:
Median
Contents:
>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference
tsRNA Information
tsRNA Name:
AS-tDR-008401
tsRNA Type:
i-tRF
Amino acid and Anticodon:
LysCTT
Sequence:
ACTCTTAATCCCAGGGTCGTG
Related Target:
N/A
Predicted Target:
SERAC1//PIGW//FAM53C//CCDC170//HNRNPM//CLCN2//IRX3//TALDO1//ARIH2//ARHGEF17
External Links:
MINTbase ID:
tRF-21-E7UMKKSW0
tRFdb ID:
N/A
[1] gtRNAdb_ID:
tRNA-Lys-CTT-6-1
Anticodon:
LysCTT
tRNA_number:
trna4
Chromosome:
18
Strand:
-
Coordinate:
Start Site(bp): 43669293 End Site(bp): 43669313
[2] gtRNAdb_ID:
tRNA-Lys-CTT-1-1
Anticodon:
LysCTT
tRNA_number:
trna13
Chromosome:
14
Strand:
-
Coordinate:
Start Site(bp): 58706635 End Site(bp): 58706655
[3] gtRNAdb_ID:
tRNA-Lys-CTT-1-2
Anticodon:
LysCTT
tRNA_number:
trna2
Chromosome:
15
Strand:
+
Coordinate:
Start Site(bp): 79152934 End Site(bp): 79152954
tsRNA Association Statistics
Total Associated Disease Number:
2
More Information
Network:
(Display the first 15 nodes)
Disease Information
MeSH
Disease Ontology
Disease ID:
D009404
N/A
Disease Name:
Nephrotic Syndrome
N/A
Category:
MeSH
Disease Ontology
Type:
N/A
N/A
Define:
N/A
N/A
Alias:
Congenital nephrotic syndrome 1//Congenital nephrotic syndrome, Finnish type//Finnish congenital nephrosis//Nephrosis 1, congenital, Finnish type//Nephrotic Syndrome, Early-Onset, Type 3//Nephrotic Syndrome, Idiopathic//Nephrotic Syndrome, Type 1//Nephrotic Syndrome, Type 2//Nephrotic Syndrome, Type 3//Nphs3
N/A
Disease Association Statistics
Total Associated tsRNA Number:
209
More Information
Network:
(Display the first 15 nodes)
Evidence Support
Strong Evidence:
N/A
Weak Evidence:
High-throughput sequencing
Reference
[1] PubMed ID:
32685525
Disease Name:
Nephrotic Syndrome
Tissue:
Podocyte
Dysfunction Pattern:
Down-Regulation
Validated Method:
High-throughput sequencing
Description:
N/A
Comparision:
Adriamycin-treated Group VS None
Mechanism:
N/A